Alastair Garfield Rhythm Pharmaceuticals, Inc. (RYTM) insider trading activity

RYTM Quotes by TradingView

Alastair Garfield is Chief Scientific Officer of RHYTHM PHARMACEUTICALS, INC.. Currently has a direct ownership of 3,126 shares of RYTM, which is worth approximately $210,411. The most recent transaction as insider was on Jul 02, 2025, when has been sold 1,319 shares (Common Stock) at a price of $64.7 per share, resulting in proceeds of $85,339. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.13K
n/a 3M change
n/a 12M change
Total Value Held $210,411

Alastair Garfield Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 02 2025
SELL
Open market or private sale
$85,339 $64.7 p/Share
1,319 Reduced 29.67%
3,126 Common Stock
Jul 01 2025
BUY
Exercise of conversion of derivative security
-
4,445 Added 50.0%
4,445 Common Stock
AG

Alastair Garfield

Chief Scientific Officer
Boston, MA

Track Institutional and Insider Activities on RYTM

Follow RHYTHM PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RYTM shares.

Notify only if

Insider Trading

Get notified when an Rhythm Pharmaceuticals, Inc. insider buys or sells RYTM shares.

Notify only if

News

Receive news related to RHYTHM PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RYTM